Local Regulatory Experts
Connect with regulatory affairs consultancies specializing in this region.
Qualtech Consulting Corporation
Taiwan, China, Japan, Singapore, Hong Kong, Malaysia, Philippines, Vietnam, Australia, Germany, Korea, Thailand, USA
A specialized medical device consulting firm offering a one-stop solution for complex global regulatory challenges. We offer real-time regulatory and clinical support, local representation, and QMS services across 13 markets, ensuring efficient market entry and compliance.
Cobridge Co., Ltd.
Tokyo, Japan
We assist medical device companies with the medical device registration and approval in Japan. Regulatory consulting services and DMAH services for foreign manufacturers to enter Japanese market.
MDREX, Medical Device, Digital Health Consulting Group
Seoul, Republic of Korea (HQ), Japan Office
We offer total solutions for market entry in South Korea and global expansion (e.g., Japan, USA, Europe). Key areas include product approval, reimbursement listings (HIRA), and Quality System certification (KGMP). They are particularly strong in innovative products like SaMD, medical wearables, and 3D printing for medical use, and provide in-depth expertise in cybersecurity and clinical trial planning.
CMIC Holdings Co., Ltd.
Tokyo, Japan (HQ), Osaka, Japan, Beijing, China, Seoul, South Korea, Taipei, Taiwan, Singapore, New York, USA, London, UK, Frankfurt, Germany, Sydney, Australia
We operate globally, specializing in accelerating the development, manufacturing, and commercialization of drugs and medical devices. Their expertise spans Phase I to IV clinical trials, regulatory affairs, quality assurance, and manufacturing, with a strong focus on the Japanese and Asian markets. Key services include clinical operations (CRO), manufacturing (CDMO/CMO), site management (SMO), and comprehensive health analysis and solutions.
January 6, 2026
Approximately 5 minutes
Procedures for Public Release of Information on Review of Applications for New Medical Devices in Japan
Procedures for Public Release of Information on Review of Applications for New Medical Devices in Japan
1. Background and Purpose
The Procedures for Public Release of Information on Review of Applications for New Medical Devices (PMDA Notification No. 0206007, February 6, 2009) establishes how information about the review process of new medical device applications is to be released publicly by the Pharmaceuticals and Medical Devices Agency (PMDA) at the request of the Evaluation and Licensing Division, Ministry of Health, Labour and Welfare (MHLW). The procedures aim to make review information available promptly while balancing confidentiality.
2. Submission of Draft Masked Documents
Applicants for new medical device approval must submit draft versions of the masked review report and masked Summary Technical Document (STED) to PMDA within two weeks of receiving a request from the Director of the Office of Medical Devices Evaluation. If both cannot be submitted simultaneously, the draft masked review report should be submitted first.
3. Masking and Adjustment Process
After submission, PMDA reviews the draft masked documents and provides comments. Applicants may raise objections and discuss specific reasons with PMDA staff to adjust the masked documents before public release. Once adjustments are completed, applicants are requested to submit the final electronic test files.
4. Timing of Public Release
The Director Notification encourages applicants to ensure the review report is made public immediately after approval and the masked STED no later than three months after approval. If adjustments are not complete by those dates, PMDA may publish the partially masked report with “Under Adjustment” noted, and later replace it with the final document once adjustments are finished.
5. Masking Principles
When preparing masked documents, information that could identify individuals or harm company interests may be minimized, but key details such as application and approval dates must not be masked. Units, standards, country names where tests were done, and details of clinical studies (with privacy safeguards where required) are generally not to be masked. The applicant must also explain the purpose of public release and ensure consent from information or device providers.
6. Practical Implications for Applicants
These procedures help ensure transparency of the regulatory review process in Japan, enabling stakeholders and the public to access summarized findings and technical details while safeguarding sensitive commercial and personal data. Applicants should prepare masked reports carefully and engage with PMDA on adjustments to facilitate timely public release.
References
- PMDA Notification No. 0206007 — Procedures for Public Release of Information on Review of Applications for New Medical Devices (Provisional Translation, March 2011)
Have a Question?
Ask our experts about this topic. We'll do our best to respond to your question.
Related Articles
Approximately 5 minutes
Japan Medical Device Registration: Pathways and Requirements
The medical device registration process in Japan is overseen by the PMDA and varies significantly based on device classification (Class I to IV). Key pathways include Pre-Market Submission (PMS), Pre-Market Certification (PMC), and Pre-Market Approval (PMA).
Approximately 5 minutes
Japan Medical Device Local Labeling Requirements: Tempu Bunsho
Medical device labeling in Japan, specified by PMDA's Article 52, mandates the use of Japanese 'tempu bunsho' (package inserts/IFUs). This process involves rigorous content requirements, notification upon revision, and MAH/DMAH oversight for affixation.
Approximately 5 minutes
Japan Medical Device Post-Market Surveillance (PMS): GVP and Adverse Event Reporting
An overview of Japan's PMS requirements under the PMD Act, focusing on the MAH's GVP compliance, the mandatory reporting of adverse events (Fuguai), and the strict reporting timelines (e.g., 15 days for death or serious, unanticipated events).
Approximately 5 minutes
Japan Specialty Fulfillment for Medical Devices: Low Volume, High Value Sales
Specialty Fulfillment is a crucial service for foreign medical device manufacturers targeting low-volume, high-value sales in Japan, often utilizing an Independent License Holder to manage customs, storage, and distribution to maintain high profit margins.
Approximately 5 minutes
Regulatory Science in Japan: PMDA’s Evidence-Based Approach to Innovation and Public Health
This article explains what “regulatory science” means in Japan and how the PMDA advances it through organizational structures, expert deliberation, collaborations, and research dissemination. A practical Q&A is included for industry and academia.